Unlike Opioids, Marijuana Doesn’t Increase Pain Sensitivity

 Unlike Opioids, Marijuana Doesn’t Increase Pain Sensitivity

“Pills” by Ben Harvey via Creative Commons.

Regular marijuana  users just got good news: Unlike opioids, cannabis doesn’t increase pain sensitivity, according to a new study from the University of British Columbia

The study offers a better glimpse into the largely unexplored effects of routine cannabis use on pain tolerance. The research indicates that marijuana can act as an alternative to opioids, which come with the risk of addiction and which have led to the staggering overdose epidemic ripping through all corners of America. 

“Recent years have seen an increase in the adoption of cannabinoid medicines, which have demonstrated effectiveness for the treatment of chronic pain,” says Michelle St. Pierre, the studies author who is a psychology researcher at UBC Okanagan, “However, the extent to which frequent cannabis use influences sensitivity to acute pain has not been systematically examined.” 

While the study is promising, the researchers welcome more research. Still, they’re ecstatic that marijuana bested opioids in their study. 

“Increases in pain sensitivity with opioids can really complicate an already tough situation; given increasing uptake of cannabis-based pain medications, it’s a relief that we didn’t identify a similar pattern with cannabinoids,” stated the study’s co-author Zach Walsh, who leads the UBC Therapeutic Recreational and Problematic Substance Use Lab which hosted the study. 

The study compared people who abstained from cannabis use to those who used it more than three times a week. Study participants took part in a cold-pressor task test, in which they held a hand and forearm in ice-water to assess pain levels. 

That helped the researchers conclude that unlike long-term opioid consumption, regular cannabis use does not increase pain sensitivity. The finding could bring relief to millions. 

“Our results suggest frequent cannabis use did not seem to be associated with elevated sensitivity to experimental pain in a manner that can occur in opioid therapy,” noted St. Pierre, “This is an important distinction that care providers and patients should consider when selecting options for pain management. These findings are particularly relevant in light of recent reports of opioid overprescribing and high rates of pain in the population, as it suggests that cannabis may not carry the same risk of hyperalgesia as opioids.” 

Dylan Croll

Dylan Croll

Dylan Croll is a freelance writer based in California. In the past, he’s worked at the Laslo Congressional Bureau, as a CollegeFix Fellow at The Weekly Standard, Norwood News, and in public relations. He can be found on Twitter at @CrollonPatrol

Subscribe To Our Newsletter

 

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!